Vimta Labs Ltd - Stock Valuation and Financial Performance

BSE: 524394 | NSE: VIMTALABS | Pharmaceuticals & Drugs | Small Cap

Vimta Labs Share Price

554.20 0.80 0.14%
as on 31-Oct'24 16:01

DeciZen - make an informed investing decision on Vimta Labs

Overall Rating
Bole Toh

1. Quality

2. Valuation

Overvalued

3. Price Trend

Semi Strong

Vimta Labs stock performance -

mw4me loader
P/E Ratio (SA):
31.72
Market Cap:
1,231.3 Cr.
52-wk low:
390.6
52-wk high:
699.3

Is Vimta Labs Ltd an attractive stock to invest in?

1. Is Vimta Labs Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Vimta Labs Ltd is a average quality company.

2. Is Vimta Labs Ltd undervalued or overvalued?

The key valuation ratios of Vimta Labs Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Vimta Labs Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Vimta Labs Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Vimta Labs:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Vimta Labs Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 5.8%7%11.2%16.6%20.4%6%14.2%23.9%24.3%17%-
Value Creation
Index
-0.6-0.5-0.20.20.5-0.60.00.70.70.2-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 107125154183213181209276315313311
Sales YoY Gr.-16.3%23.4%19.2%15.9%-15%15.7%32%14.2%-0.7%-
Adj EPS 2.22.957.511.32.69.8192117.317.5
YoY Gr.-31.5%71.9%51.9%49.7%-76.7%272.1%95%10.4%-17.7%-
BVPS (₹) 55.35761.668.877.678.287.9104.4123.9139.6144.6
Adj Net
Profit
4.86.410.916.624.95.821.64246.538.339
Cash Flow from Ops. 15.3-123.933.439.324.43758.786.559.1-
Debt/CF from Ops. 0.2-25.61.81.20.71.30.80.30.20.3-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 12.6%8%14.4%-0.7%
Adj EPS 25.8%8.9%21%-17.7%
BVPS10.8%12.5%16.7%12.7%
Share Price 19.2% 36.8% 17.6% 26.1%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
45.18.311.515.43.411.719.618.112.812.3
Op. Profit
Mgn %
16.215.218.124.827.216.625.42929.726.726.8
Net Profit
Mgn %
4.55.17.19.111.73.210.315.214.712.212.5
Debt to
Equity
00.20.30.30.20.20.20.10.10.1-
Working Cap
Days
18719918716815819518615814815692
Cash Conv.
Cycle
1121189992101128113959210759

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 14.39%

Net Profit is growing at healthy rate in last 3 years 20.99%

Return on Equity has declined versus last 3 years average to 12.30%

Sales growth is not so good in last 4 quarters at -2.36%

Latest Financials - Vimta Labs Ltd.

Standalone Consolidated
TTM EPS (₹) 17.5 18.5
TTM Sales (₹ Cr.) 311 317
BVPS (₹.) 144.6 146.4
Reserves (₹ Cr.) 317 321
P/BV 3.83 3.79
PE 31.72 29.96
From the Market
52 Week Low / High (₹) 390.60 / 699.25
All Time Low / High (₹) 0.20 / 699.25
Market Cap (₹ Cr.) 1,231
Equity (₹ Cr.) 4.4
Face Value (₹) 2
Industry PE 46.8

Management X-Ray of Vimta Labs:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Vimta Labs

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales107125154183213181209276315313
Operating Expenses 90106127138155151156196222229
Manufacturing Costs46535959686368908790
Material Costs-3002-103000
Employee Cost 29334349555857718695
Other Costs 18192428332928364945
Operating Profit 17192745583053809484
Operating Profit Margin (%) 16.2%15.1%17.8%24.7%27.1%16.6%25.2%28.9%29.7%26.7%
Other Income 1111231134
Interest 1125542132
Depreciation 11101016202123233134
Exceptional Items 0000000-100
Profit Before Tax 78172635828556452
Tax 22691017141713
Profit After Tax 56111625721414739
PAT Margin (%) 4.7%5.2%6.9%9.0%11.9%3.8%10.2%14.9%15.0%12.4%
Adjusted EPS (₹)2.32.94.87.411.53.19.618.621.417.5
Dividend Payout Ratio (%)44%34%0%27%17%0%21%11%9%11%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 122126136152172173194231274310
Share Capital 4444444444
Reserves 118122132148167169190226270305
Minority Interest0000000000
Debt4263733172222131014
Long Term Debt01618191251413109
Short Term Debt41019135188005
Trade Payables76151311101512148
Others Liabilities 14183335383941495856
Total Liabilities 146176222232237244272304356388

Fixed Assets

Gross Block22223198166180197216266300328
Accumulated Depreciation1341431025456688105133165
Net Fixed Assets888888140135131128162168163
CWIP 06530421701259
Investments 0000066666
Inventories16161518191715172325
Trade Receivables26384256595873778086
Cash Equivalents 1313377113924
Others Assets15252215182426302825
Total Assets 146176222232237244272304356388

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 15-12433392437598759
PBT 78172635828556452
Adjustment 12111223302329313937
Changes in Working Capital -1-191-9-16-1-13-11-4-15
Tax Paid -1-2-5-6-10-6-7-17-12-15
Cash Flow From Investing Activity -8-16-39-24-16-20-32-38-57-75
Capex -8-16-40-24-16-14-32-39-50-73
Net Investments 00000010-9-3
Others 00011-60112
Cash Flow From Financing Activity -91913-8-23-1-5-16-11-2
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 01682-7-67-3-5-1
Interest Paid 0-1-2-4-3-2-2-1-1-1
Dividend Paid -4-2-30-5-50-4-4-4
Others -469-6-812-9-805
Net Cash Flow -12-21131519-17
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)4.175.188.0811.415.644.0211.5819.3218.7313.29
ROCE (%)5.826.9511.2216.5520.426.0114.2423.8524.2517
Asset Turnover Ratio0.730.770.770.810.910.750.810.960.950.84
PAT to CFO Conversion(x)3-0.172.182.061.563.431.761.441.851.51
Working Capital Days
Receivable Days9293959898117114999197
Inventory Days45463733323728212328
Payable Days-778002,187-5,63101,517000

Vimta Labs Ltd Stock News

Vimta Labs Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Vimta Labs on 31-Oct-2024 16:01 is ₹554.2.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Oct-2024 16:01 the market cap of Vimta Labs stood at ₹1,231.3.
The latest P/E ratio of Vimta Labs as of 31-Oct-2024 16:01 is 31.72.
The latest P/B ratio of Vimta Labs as of 31-Oct-2024 16:01 is 3.83.
The 52-week high of Vimta Labs is ₹699.2 and the 52-week low is ₹390.6.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Vimta Labs is ₹310.9 ( Cr.) .

About Vimta Labs Ltd

Vimta Labs is India’s leading contract research and testing organization. Established in 1984, Vimta has an envious track record of serving several market leaders across the globe.

Vimta supports regulatory authorities in mandatory certification of food and agri products exported from India. Vimta assists the food industry commissions for nutritional labelling, food safety evaluations, trace analysis and shelf life studies.

Vimta has a team of 684 professionals comprising 446 scientists in various disciplines such as chemistry, pharma, medicine, microbiology, molecular biology and informatics. The team is slated to double in next three years.

Vimta is a multi-site organization with more than 300,000 sqft world class laboratory facilities. The technologies deployed at Vimta are current and leading edge, duly validated.

Vimta has over 12 years of experience in providing preclinical services to Pharma companies world-wide accordance with the guidelines prescribed by international agencies.

Vimta has a state-of-art building of Class 10,000 Pre-clinical facility with a total built up area of 33,000 sq.ft. with 32 rodent experimental rooms, 5 procedure rooms, separate quarantine facility and distinct non-rodent facility with 48 SS kennels with a comfortable perch, liberal exercise area.

It provides services in pharmacology, toxicology and DMPK areas. The toxicology services include but not limited to in-vivo and in-vitro genotoxicity, acute to chronic toxicity, carcinogenicity, reproductive toxicity studies, safety pharmacology, and immunotoxicology. Pharmacology services are available in various therapeutics areas such as pain & inflammation, metabolic disorders, respiratory, CNS, and xenograft & allograft models for oncology. In addition to the regulatory studies we use tailor-made in vitro and in vivo ADME techniques to help profile your drug candidate in both rodent and non-rodent animals models.

Services offered by the company:

  • Advanced Molecular Biology
  • Food and Agriculture
  • Drugs & Pharma
  • Water
  • Environmental Assessments
  • Clinical Research
  • Clinical Reference Lab Services
  • Preclinical Research
  • Genomics Online Ordering

 Achievements/ recognition

  •    NABL as per ISO 15189:2007
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.